Welcome to our dedicated page for Marsh & Mclennan SEC filings (Ticker: MMC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Marsh & McLennan Companies, Inc., doing business as Marsh McLennan, files reports with the US Securities and Exchange Commission as a public company with common stock listed on the New York Stock Exchange. This SEC filings page for MMC provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other filings that document material events, governance changes and financial reporting updates.
Recent Form 8-K filings illustrate the types of information Marsh McLennan reports. One filing describes amendments and restatements of the company’s bylaws, noting updates to align with changes in the Delaware General Corporation Law, revisions to advance notice provisions for director nominations and stockholder proposals, clarification of voting standards for matters submitted to stockholders, and clarification of the authority of the chair of stockholder meetings. Other 8-K filings disclose quarterly financial results, conference calls to discuss those results, and board-level changes such as the appointment of an independent director to the Board and Audit Committee.
Filings also show details about Marsh McLennan’s capital structure and listing status, including the registration of its common stock, par value $1.00 per share, and the trading symbols under which it is listed on the New York Stock Exchange. Investors can review these filings to understand how Marsh McLennan communicates material events, corporate governance changes and financial information.
On Stock Titan, Marsh McLennan’s SEC filings are paired with AI-powered tools that can help explain the contents of lengthy documents, highlight key sections, and surface items such as current reports, annual and quarterly reports, and disclosures about governance or board changes. This makes it easier to navigate Marsh McLennan’s regulatory history, track updates over time, and connect specific filings to news and other public communications about the company.
Marsh & McLennan Companies reported that Nicholas Mark Studer, President and CEO of Marsh Risk, received a grant of 5,766 restricted stock units on common stock as equity compensation. The units were granted at no cash cost and convert into common stock on a 1-for-1 basis.
These restricted stock units are scheduled to vest on April 15, 2029. Following this grant, Studer holds 5,766 restricted stock units directly under this award, reflecting a routine long-term incentive grant rather than an open-market share purchase or sale.
Marsh & McLennan Companies has issued its 2026 proxy statement for a virtual annual meeting on May 21, 2026, seeking shareholder approval to elect 13 directors, hold an advisory vote on executive pay, and ratify Deloitte & Touche as auditor. Marsh reports 2025 revenue of $27.0 billion, up 10% on a GAAP basis with 4% underlying revenue growth, GAAP EPS up 3% and adjusted EPS up 9%. GAAP operating income grew 7% and adjusted operating income 11%, with adjusted margin expanding for the 18th consecutive year. Five-year annualized TSR of 11.3% beat the S&P 500 Equal Weight Index but trailed the S&P 500, while 2025 TSR was -11.3%. The company returned capital through a record $2.0 billion share repurchase and about $1.7 billion in dividends, and invested roughly $850 million in 20 acquisitions that added $255 million of revenue. A new three-year “Thrive” program is expected to generate approximately $400 million in annualized savings. Executive bonuses were set above target and 2023 PSU awards paid out at 176% of target based on 12.7% three-year annualized adjusted EPS growth and relative TSR.
Marsh & McLennan Cos Inc: The Vanguard Group filed Amendment No. 10 to its Schedule 13G/A reporting that it beneficially owns 0 shares of Marsh & McLennan Common Stock. The filing explains an internal realignment effective January 12, 2026 and reliance on SEC Release No. 34-39538 to disaggregate certain subsidiaries' holdings. The form is signed by Ashley Grim, Head of Global Fund Administration on 03/27/2026.
Marsh & McLennan Companies executive Patrick Tomlinson, President and CEO of Mercer, reported the vesting and conversion of restricted stock units into common stock. On March 15, 2026, 1,228 RSUs converted into 1,228 shares of common stock on a 1-for-1 basis. Of these, 627 shares were withheld by the company at $172.15 per share to cover applicable taxes, leaving Tomlinson with additional net shares and 4,256 common shares held directly after the transactions. No remaining derivative positions are shown in this filing, indicating a routine compensation-related vesting with tax withholding rather than an open-market trade.
Marsh & McLennan Companies Chief Marketing Officer John Jude Jones reported an open-market sale of common stock. On March 11, 2026, he sold 2,362 shares at an average price of $173.6101 per share. After the sale, he directly held 7,978 shares, with an additional 1,819.885 shares held indirectly through the MMC 401(k) Savings & Investment Plan.
Marsh & McLennan Companies, Inc. announced leadership changes at its Marsh Risk business and updated compensation terms for a senior executive. Nick Studer will become President and Chief Executive Officer of Marsh Risk effective April 1, 2026, succeeding Martin South. Mr. Studer has led Oliver Wyman and Marsh Management Consulting since July 2021 and has held multiple senior roles at the firm since joining in 1997.
Mr. South will become Senior Vice President and Chief Client Officer of Marsh & McLennan Companies, also effective April 1, 2026. Both executives will remain on the Company’s Executive Committee and continue to report to John Doyle, President and Chief Executive Officer of the Company. The Compensation Committee approved an amendment under which Mr. South keeps his current base salary and becomes eligible for an annual bonus with a target of $1,500,000 starting with the 2026 performance year and a long-term incentive award with a target value of $1,750,000 beginning with the 2027 award cycle.
From April 1, 2026 for 12 months, if Mr. South is involuntarily terminated without “Cause” or resigns for any reason, he will receive severance benefits as if he had been involuntarily terminated without Cause as of that date under the Senior Executive Severance Pay Plan. Beginning April 1, 2027, he will participate in the Severance Plan on the same terms as other eligible employees. The Company issued a press release providing additional background on these appointments.
Marsh & McLennan Companies, Inc. President and CEO John Q. Doyle exercised stock options and sold shares on March 4, 2026. He exercised options for 16,655 Stock Options (Right to Buy) at $0.0000 per share, leaving 49,968 options held directly. He then sold 16,655 shares of Common Stock at an average price of $183.3000 per share in an open‑market transaction under a previously adopted Rule 10b5‑1 trading plan, and held 116,811.0205 common shares directly afterward.
Marsh & McLennan Companies executive Nicholas Mark Studer reported an open-market sale of 3,837 shares of common stock. The shares were sold on March 3, 2026 at an average price of $184.0299 per share to satisfy tax withholding obligations. After this transaction, he directly holds 32,536 shares of the company.